Supplement: Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study

Published: 01-10-2020| Version 1 | DOI: 10.17632/xhfzxp9nfp.1
Contributor:
Maria Schneeweiss

Description

Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study

Files